钙调蛋白拮抗剂对人胃癌细胞效应机理的研究——钙调蛋白与磷酸二酯酶活性测定分析
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目.


STUDIES ON THE MECHANISMS OF THE ACTION OF CALMODULIN ANTAGONIST——TRIFLUOPERAZINE ON CULTURED HUMAN STOMACH CARCINOMA CELLS: QUANTITATIVE ANALYSIS OF CALMODULIN AND PHOSPHODIESTERASE ACTIVITIES
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    我们曾经证明钙调蛋白(Calmodulin,CaM)拮抗剂三氟拉嗪(Trifluoperazine,TFP)有抑制人胃癌细胞增殖和诱导细胞形态向正常分化的效应。本文用CaM活性测定箱方法测定了TFP处理的人胃癌MGC-803细胞胞质内的CaM活性。同时也测定了磷酸二酯酶(Phosphodiesterase.PDE)活性的变化。结果表明TFP选择性抑制胞质内依赖Ca2+/CaM的PDE活性。氨茶碱有抑制CaM活化PDE的作用。本文对TFP作用机理及在调控癌细胞增殖及分化中的意义进行讨论。

    Abstract:

    Motivated by our earlier demonstration that calmodulin (CaM) antagonist-trifluoperazine (TFP) effectively inhibits cell proli feration and DNA synthesis in human stomach carcinoma MGC-803 cells with simultaneous induction of normalized cell morphology, this work was designed to investigate the mechanisms of TFP effect on MGC-803 cells By using biochemical assays, CaM and phosphodiesterase(PDE) activities in TFP treated MGC-803 cells were quantitatively analyzed with comparison to untreated control cells. TFP treated mouse ascitic hepatoma cells were analyzed as parallel. Results indicate that TFP selectively inhibits Ca2+/CaM-dependent PDE activity rather than the PDE-binding activity of CaM in drug-treated cells of both types. However, both MGC-803 and mouse hepatoma cells exposed: to aminophylline (2mmol/L) for 3 days or shorter time showed decrease in PDE-binding activity of CaM. The possible mechanisms concerning TFP effects and their role in regulating cell proliferation of MGC-803 cells were discussed.

    参考文献
    相似文献
    引证文献
引用本文

赵雅丽,孟松娘,刘树人,林仲翔.钙调蛋白拮抗剂对人胃癌细胞效应机理的研究——钙调蛋白与磷酸二酯酶活性测定分析[J].生物化学与生物物理进展,1991,18(2):118-122

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:1990-02-20
  • 最后修改日期:1990-04-20
  • 接受日期:
  • 在线发布日期:
  • 出版日期: